About Kazumi Shiosaki
Form D filings for Redona Therapeutics from 2018 to 2023 list Kazumi Shiosaki as president and chief executive officer, director.
Kazumi Shiosaki first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Kazumi Shiosaki in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kazumi Shiosaki works with at each company, as listed on that company's latest Form D.
Redona Therapeutics, Inc. · Form D, Jul 31, 2023
MS
Michal Silverberg
Director
LE
Luke Evnin
Director
HR
Henrijette Richter
Director
CB
Christine Brennan
Director